Oyster Point Pharma, Inc. Earnings Per Share, Basic and Diluted
Oyster Point Pharma, Inc. reported Earnings Per Share, Basic and Diluted of -$2.92 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-18.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-02-18
- Oyster Point Pharma, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.86.
- Oyster Point Pharma, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.63.
- Oyster Point Pharma, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.66.
- Oyster Point Pharma, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.77.
- Oyster Point Pharma, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.92.
- Oyster Point Pharma, Inc. earnings per share, basic and diluted for fiscal 2019 was -$9.97.
- Oyster Point Pharma, Inc. earnings per share, basic and diluted for fiscal 2018 was -$11.69.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$0.86 derived: net income ÷ weighted average shares · filed 2021-02-18 | -$1.49 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$2.16 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$2.92 10-K · filed 2021-02-18 |
| 2020-09-30 | -$0.63 10-Q · filed 2020-11-05 | -$1.29 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$2.05 10-Q · filed 2020-11-05 | -$3.22 derived: net income ÷ weighted average shares · filed 2021-11-04 |
| 2020-06-30 | -$0.66 10-Q · filed 2020-08-05 | -$1.43 10-Q · filed 2020-08-05 | -$2.64 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$4.20 derived: net income ÷ weighted average shares · filed 2021-11-04 |
| 2020-03-31 | -$0.77 10-Q · filed 2020-05-11 | -$2.05 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$3.89 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$6.12 derived: net income ÷ weighted average shares · filed 2021-11-04 |
| 2019-12-31 | -$1.41 derived: net income ÷ weighted average shares · filed 2021-02-18 | -$4.05 derived: net income ÷ weighted average shares · filed 2021-02-18 | -$7.48 derived: net income ÷ weighted average shares · filed 2021-02-18 | -$9.97 10-K · filed 2021-02-18 |
| 2019-09-30 | -$8.10 10-Q · filed 2020-11-05 | -$15.70 derived: net income ÷ weighted average shares · filed 2021-02-18 | -$18.37 10-Q · filed 2020-11-05 | -$21.22 derived: net income ÷ weighted average shares · filed 2021-02-18 |
| 2019-06-30 | -$7.60 10-Q · filed 2020-08-05 | -$10.26 10-Q · filed 2020-08-05 | -$13.10 derived: net income ÷ weighted average shares · filed 2021-02-18 | -$17.80 derived: net income ÷ weighted average shares · filed 2021-02-18 |
| 2019-03-31 | -$2.66 10-Q · filed 2020-05-11 | -$5.50 derived: net income ÷ weighted average shares · filed 2021-02-18 | -$10.20 derived: net income ÷ weighted average shares · filed 2021-02-18 | -$12.27 derived: net income ÷ weighted average shares · filed 2021-02-18 |
| 2018-12-31 | -$2.84 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$7.54 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$9.61 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$11.69 10-K · filed 2020-02-27 |
| 2018-09-30 | -$4.70 10-Q · filed 2019-12-03 | -$6.77 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$8.85 10-Q · filed 2019-12-03 | |
| 2018-06-30 | -$2.07 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$4.15 derived: net income ÷ weighted average shares · filed 2020-02-27 | ||
| 2018-03-31 | -$2.08 derived: net income ÷ weighted average shares · filed 2020-02-27 |